Doucet Laurent
Communications des JTF
Sur HAL :
Cette recherche s'effectue à partir des nom et prénom de l'auteur (authFullName_t) et non de son identifiant unique Hal (authIdHal_t) ; les résultats peuvent être incomplet ou présenter quelques productions d'autres auteurs (homonymes, nom composé avec espaces ou tirets, etc.).
27 documents
- Clara Bastard, Charline Caumont, Laura Samaison, Isabelle Quintin-Roué, Laurent Doucet, et al.. Fluorescent In Situ Hybridization Testing Allows the Diagnosis of NRG1 Gene Fusions in Lung and Pancreas Cancers with No Other Identified Oncogenic Driver. Cancers, 2025, 17, ⟨10.3390/cancers17142347⟩. ⟨hal-05224407⟩
- Tom Drossart, Alexandre Buffet, Ali Janbain, Chris Ottolenghi, Laurence Amar, et al.. Biomarkers Improving Genetic and Metastatic Disease Prediction in Paraganglioma: Insights From a Prospective Study. Journal of Clinical Endocrinology and Metabolism, 2024, ⟨10.1210/clinem/dgae797⟩. ⟨hal-04839328⟩
- Thibault Kervarrec, Kuan Cheok Lei, Pierre Sohier, Nicolas Macagno, Marie-Laure Jullie, et al.. Wnt/ß-catenin-activated nonpilomatrical carcinoma of the skin: a case series. Modern Pathology, 2024, 37 (11), pp.100586. ⟨10.1016/j.modpat.2024.100586⟩. ⟨hal-04676587⟩
- Claire Bocciarelli, Pierre-Guillaume Poureau, Arnaud Uguen, Laurent Doucet. Confrontation morphologique et immunophénotypique pour le diagnostic d’une tumeur gastrique rare. Annales de Pathologie, 2024, 44 (1), pp.78-81. ⟨10.1016/j.annpat.2023.08.001⟩. ⟨hal-05232988⟩
- Anaïs Mercier, Virginie Conan-Charlet, Isabelle Quintin-Roué, Laurent Doucet, Pascale Marcorelles, et al.. Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?. Cancers, 2023, 15 (10), pp.2768. ⟨10.3390/cancers15102768⟩. ⟨hal-05230278⟩
- Margaux Pacaud, Thibault Kervarrec, Julien Masliah-Planchon, Anne Tallet, Christine Collin, et al.. Merkel cell carcinoma from renal transplant recipients are mostly MCPyV ‐negative and are frequently associated with squamous cell carcinomas or precursors. Journal of the European Academy of Dermatology and Venereology, 2023, 37 (8), pp.e1014-e1018. ⟨10.1111/jdv.19076⟩. ⟨hal-04076149⟩
- Emeric Boisteau, Alexandra Lespagnol, Marie de Tayrac, Sébastien Corre, Anthony Perrot, et al.. MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩. ⟨hal-03595901⟩
- Capucine Bres, Thibault Voron, Leonor Benhaim, Damien Bergeat, Yann Parc, et al.. Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network. Annals of Surgery, 2022, 276 (5), pp.830-837. ⟨10.1097/SLA.0000000000005626⟩. ⟨hal-04012352⟩
- Vincent Lethongsavarn, Michele Pinault, Abdoulaye Diedhiou, Cyrille Guimaraes, Roseline Guibon, et al.. Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno-geographic variations. Prostate, 2021, 81 (16), pp.1365-1373. ⟨10.1002/pros.24234⟩. ⟨hal-03361034⟩
- Vincent Bourbonne, Vincent Jaouen, Truong An Nguyen, Valentin Tissot, Laurent Doucet, et al.. Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients. Cancers, 2021, 13, pp.5672. ⟨10.3390/cancers13225672⟩. ⟨hal-05067690⟩
Documents récupérés de l'archive ouverte HAL 
